SANTA CLARA, Calif.--(BUSINESS WIRE)--May 7, 2018--
Agilent Technologies Inc. (NYSE: A) today announced that it has
completed the acquisition of Lasergen, Inc. (Lasergen), an emerging
biotechnology company focused on research and development of innovative
technologies for DNA sequencing.
In March 2016Agilent made an initial investment in the Houston, Texas
based privately-held company to acquire a 48-percent ownership stake
with a two-year call option to acquire the remaining shares for $105
million. Agilent gave its notice of exercise on February 23, 2018.
“We are pleased to complete our acquisition of Lasergen,” said Sam Raha,
president of Agilent’s Diagnostics and Genomics Group. “We are excited
to welcome our Lasergen colleagues to the Agilent family, and look
forward to continuing our work as one team focused on building a
next-generation sequencing workflow for clinical applications.”
Since Agilent’s initial investment, Lasergen and Agilent have been
collaborating to develop a workflow solution for clinical applications
based on next-generation sequencing leveraging Lasergen’s Lightning
Terminators™ chemistry.
“In 2016 we began our collaboration with Lasergen that reinforced our
confidence in the team and technology,” said Kamni Vijay, vice president
and general manager of Agilent’s Genomics division. “As a unified team,
we now have new opportunities to leverage our combined strengths and
create significant value for our customers as we work towards our goal
of creating an integrated clinical workflow solution and providing more
labs with access to molecular diagnostics.”
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences,
diagnostics, and applied chemical markets. With more than 50 years of
insight and innovation, Agilent instruments, software, services,
solutions, and people provide trusted answers to its customers' most
challenging questions. The company generated revenues of $4.47 billion
in fiscal 2017 and employs 14,200 people worldwide. Information about
Agilent is available at www.agilent.com.
Forward-Looking Statements
This news release contains forward-looking statements as defined in the
Securities Exchange Act of 1934 and is subject to the safe harbors
created therein. The forward-looking statements contained herein
include, but are not limited to, information regarding Agilent’s future
revenue, earnings and profitability; planned new products; market
trends; the future demand for the company’s products and services;
customer expectations; and revenue and non-GAAP earnings guidance for
the second quarter and full fiscal year 2018. These forward-looking
statements involve risks and uncertainties that could cause Agilent’s
results to differ materially from management’s current expectations.
Such risks and uncertainties include, but are not limited to, unforeseen
changes in the strength of our customers’ businesses; unforeseen changes
in the demand for current and new products, technologies, and services;
unforeseen changes in the currency markets; customer purchasing
decisions and timing, and the risk that we are not able to realize the
savings expected from integration and restructuring activities. In
addition, other risks that Agilent faces in running its operations
include the ability to execute successfully through business cycles; the
ability to meet and achieve the benefits of its cost-reduction goals and
otherwise successfully adapt its cost structures to continuing changes
in business conditions; ongoing competitive, pricing and gross-margin
pressures; the risk that our cost-cutting initiatives will impair our
ability to develop products and remain competitive and to operate
effectively; the impact of geopolitical uncertainties and global
economic conditions on our operations, our markets and our ability to
conduct business; the ability to improve asset performance to adapt to
changes in demand; the ability of our supply chain to adapt to changes
in demand; the ability to successfully introduce new products at the
right time, price and mix; the ability of Agilent to successfully
integrate recent acquisitions; the ability of Agilent to successfully
comply with certain complex regulations; and other risks detailed in
Agilent’s filings with the Securities and Exchange Commission, including
our quarterly report on Form 10-Q for the first quarter ended January
31, 2018. Forward-looking statements are based on the beliefs and
assumptions of Agilent’s management and on currently available
information. Agilent undertakes no responsibility to publicly update or
revise any forward-looking statement.
NOTE TO EDITORS: Further technology, corporate citizenship and executive
news is available on the Agilent news site at www.agilent.com/go/news.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180507006000/en/
Source: Agilent Technologies Inc.
Agilent Technologies Inc.
EDITORIAL CONTACTS:
Victoria
Wadsworth-Hansen, +1 408-553-2005
+ 45 29336980
victoria.wadsworth-hansen@agilent.com
or
Stefanie
Notaney, +1 408-345-8955
stefanie.notaney@agilent.com
or
INVESTOR
CONTACT:
Alicia Rodriguez, +1 408-345-8948
alicia_rodriguez@agilent.com